2024-10-01 2025-09-30 false Capium Accounts Production 1.1 08690151 2024-10-01 2025-09-30 08690151 bus:AbridgedAccounts 2024-10-01 2025-09-30 08690151 bus:FRS102 2024-10-01 2025-09-30 08690151 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 08690151 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 08690151 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 08690151 2024-10-01 2025-09-30 08690151 2025-09-30 08690151 bus:RegisteredOffice 2024-10-01 2025-09-30 08690151 core:WithinOneYear 2025-09-30 08690151 core:AfterOneYear 2025-09-30 08690151 1 2024-10-01 2025-09-30 08690151 bus:Director1 2024-10-01 2025-09-30 08690151 bus:Director1 2025-09-30 08690151 bus:Director1 2023-10-01 2024-09-30 08690151 2023-10-01 08690151 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 08690151 2023-10-01 2024-09-30 08690151 2024-09-30 08690151 core:WithinOneYear 2024-09-30 08690151 core:AfterOneYear 2024-09-30 08690151 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 08690151 core:FurnitureFittings 2024-10-01 2025-09-30 08690151 core:FurnitureFittings 2025-09-30 08690151 core:FurnitureFittings 2024-09-30 08690151 core:ComputerEquipment 2024-10-01 2025-09-30 08690151 core:ComputerEquipment 2025-09-30 08690151 core:ComputerEquipment 2024-09-30 08690151 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-09-30 08690151 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 08690151 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 08690151 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 08690151 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 08690151 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 08690151 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 08690151 core:Non-currentFinancialInstruments 2025-09-30 08690151 core:Non-currentFinancialInstruments 2024-09-30 08690151 core:ShareCapital 2025-09-30 08690151 core:ShareCapital 2024-09-30 08690151 core:RetainedEarningsAccumulatedLosses 2025-09-30 08690151 core:RetainedEarningsAccumulatedLosses 2024-09-30 08690151 dpl:Item1 2024-10-01 08690151 dpl:Item1 2025-09-30 08690151 dpl:Item1 2023-10-01 08690151 dpl:Item1 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 08690151
England and Wales
EVIDENCE-BASED MEDICINE CONSULTANCY LTD
Abridged Accounts
Period of accounts Start date: 01 October 2024 End date: 30 September 2025

Evidence-Based Medicine Consultancy Ltd Contents Page For the year ended 30 September 2025
Statement of Financial Position | 1
Notes to the Financial Statements | 2

Evidence-Based Medicine Consultancy Ltd Statement of Financial Position As at 30 September 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 2,113 |  | 2,817
|  | 2,113 |  | 2,817
Current assets |  |  |
Cash at bank and in hand |  | 422 |  | (74)
Creditors: amount falling due within one year |  | (4,766) |  | (521)
Net current assets |  | (4,344) |  | (595)
Total assets less current liabilities |  | (2,231) |  | 2,222
Net assets |  | (2,231) |  | 2,222
Capital and reserves |  |  |
Called up share capital |  | 100 |  | 100
Profit and loss account |  | (2,331) |  | 2,122
Shareholders' funds |  | (2,231) |  | 2,222
For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 23 June 2026 and were signed by:
------------------------------- Theresa Lawrie Director
1

Evidence-Based Medicine Consultancy Ltd Notes to the Abridged Financial Statements For the year ended 30 September 2025
General Information Evidence-Based Medicine Consultancy Ltd is a private company, limited by shares, registered in England and Wales, registration number 08690151, registration address Building 2a - D Site Kemble Airfield, Kemble, Cirencester, Gloucestershire, GL7 6BA. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts where applicable. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 25% Reducing Balance
Computer Equipment | 25% Reducing Balance
2. | Average number of employees Average number of employees during the year was 0 (2024 : 0).
3. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Computer Equipment |  | Total
| £ |  | £ |  | £
At 01 October 2024 | 1,416 |  | 10,048 |  | 11,464
Additions | - |  | - |  | -
Disposals | - |  | - |  | -
At 30 September 2025 | 1,416 |  | 10,048 |  | 11,464
Depreciation
At 01 October 2024 | 1,206 |  | 7,441 |  | 8,647
Charge for year | 52 |  | 652 |  | 704
On disposals | - |  | - |  | -
At 30 September 2025 | 1,258 |  | 8,093 |  | 9,351
Net book values
Closing balance as at 30 September 2025 | 158 |  | 1,955 |  | 2,113
Opening balance as at 01 October 2024 | 210 |  | 2,607 |  | 2,817
2